# High-sensitivity Troponin in Cardiac Surgery

Study · id `cardio:ct-nct01913873` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01913873](<https://clinicaltrials.gov/study/NCT01913873>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01913873

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.

## Technical summary

Registry record NCT01913873. Allocation not applicable; no masking; primary purpose screening. Start 2014-01 (registry gives no type); primary completion 2015-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase: Phase 4
- Enrolled: 400 participants (enrolled count; ClinicalTrials.gov record NCT01913873, source copy `cardio:ctgov-nct01913873-2015-03-18`, retrieved 2026-10-26)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT01913873, source copy `cardio:ctgov-nct01913873-2015-03-18`, retrieved 2026-10-26)
- Primary completion: 2015-01 (actual) (ClinicalTrials.gov record NCT01913873, source copy `cardio:ctgov-nct01913873-2015-03-18`, retrieved 2026-10-26)
- Completion: 2015-03 (actual) (ClinicalTrials.gov record NCT01913873, source copy `cardio:ctgov-nct01913873-2015-03-18`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT01913873, source copy `cardio:ctgov-nct01913873-2015-03-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01913873-2015-03-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: High-sensitivity Troponin in Cardiac Surgery
- Condition: Heart; Dysfunction Postoperative, Cardiac Surgery
- Condition: Myocardial Infarction
- Condition: Myocardial Injury
- Intervention (Other): serum concentration changes cardiac biomarkers
- Lead sponsor: Onze Lieve Vrouw Hospital
- Lead sponsor class: OTHER
- Collaborator: Roche Farma, S.A
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Onze Lieve Vrouw Hospital (`cardio:org-onze-lieve-vrouw-hospital`)

## Provenance

Content hash: 958e395bd448f83868679c145da07b92976bb397dc27f16ef176dd12cf1afd64
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
